Ipsat Therapies

About:

Ipsat Therapies is a biotechnology company, developing products for the prevention of antibiotic-associated diarrhea and infections. 

Top Investors: Tesi, Varma Mutual Pension Insurance Company, Sitra, BioFund Management, Innovations Kapital

Description:

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.